
Catalyst Pharmaceuticals Investor Relations Material
Latest events

Q2 2025
Catalyst Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Catalyst Pharmaceuticals Inc
Access all reports
Catalyst Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare neurological and neuromuscular diseases. The company's portfolio includes treatments designed to address conditions such as Lambert-Eaton Myasthenic Syndrome (LEMS) and other disorders that have limited treatment options. The company is headquartered in Coral Gables, Florida, and its shares are listed on the NASDAQ.
Key slides for Catalyst Pharmaceuticals Inc


Corporate Presentation
Catalyst Pharmaceuticals Inc


Corporate Presentation
Catalyst Pharmaceuticals Inc
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
CPRX
Country
🇺🇸 United States